Omegaven
Omegaven is a dietary supplement with 40 clinical trials. Historical success rate of 84.0%.
Success Metrics
Based on 21 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
15
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
80.8%
21 of 26 finished
19.2%
5 ended early
0
trials recruiting
40
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Safety and Tolerability of Intravenous Fish Oil Lipid Emulsion in Children Undergoing Hematopoietic Cell Transplantation
Cholestasis Reversal: Efficacy of IV Fish Oil
Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in Infants
Compassionate Use of Omegaven® for the Treatment of Intestinal Failure Associated Liver Disease in Children
Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis
Clinical Trials (40)
Safety and Tolerability of Intravenous Fish Oil Lipid Emulsion in Children Undergoing Hematopoietic Cell Transplantation
Cholestasis Reversal: Efficacy of IV Fish Oil
Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in Infants
Compassionate Use of Omegaven® for the Treatment of Intestinal Failure Associated Liver Disease in Children
Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis
Omega-3 Long Chain Polyunsaturated Fatty Acid (LCPUFA) Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity
Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury
Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids -
Use of Omegaven for Treatment With Parenteral Nutrition Associated Liver Disease
Compassionate Use of an Intravenous Fish Oil Emulsion in the Treatment of Liver Injury in Infants
Omegaven Protocol:Intermediate Size Patient Population
Compassionate Use of an Intravenous Fish Oil Emulsion in Infants With Cholestasis
Use of Omega 3 Oil Emulsion for Parenteral Nutrition Associated Cholestasis
Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver Disease
Cholestasis Prevention: Efficacy of IV Fish Oil
High Dose Intravenous Fish Oil Reduces Inflammation
Omegaven as Alternative Parenteral Fat Nutrition
Compassionate Use of Omegaven to Reverse Parenteral Nutrition Induced Cholestasis
A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver Disease
Compassionate Use of Omegaven in Children
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 40